Patent · US Active

Crystalline forms of rapamycin analogs

US8030326B2 · kind B2 · utility

3Cited by

2References

15Claims

0Family size

Assignee

Abbott Laboratories · US

Inventors

Shekhar Viswanath · Maryland Heights, US
Larry Bartelt · Highland Park, US
Robert Leanna · Grayslake, US
Michael Dolberg Rasmussen · Kenosha, US
Madhup K. Dhaon · Mundelein, US
Rodger F. Henry · Park City, US
Thomas B. Borchardt · Kenosha, US
Shuang Chen · Gurnee, US
Geoff G. Zhang · Vernon Hills, US

Key dates

Filing date	Sep 20, 2010
Grant date	Oct 4, 2011
Priority date	—
Expiry date	Sep 20, 2030

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P43/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Provided is a rapamycin analog composition including a crystalline form of a rapamycin analog. The crystal can be a hydrate. dehydrate, solvate, or desolvate. The rampamycin analog can have a structure of Formula 1, which is optionally a prodrug, salt, derivative, or combination thereof:

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.